Finance

Lists
600833:SHA
Shanghai No.1 Pharmacy Co Ltd
CN¥10,34
-0,10%
(-0,010) 1D
16 Okt., 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600833...
Open
CN¥10,48
High
CN¥10,69
Low
CN¥10,20
Mkt. cap
2,40 mjd
Avg. vol.
5,31 m
Volume
5,09 m
Dividend
0,75%
Quarterly dividend
CN¥0,02
Ex-dividend date
26 Jun. 2026
P/E ratio
33,00
52-wk high
CN¥15,55
52-wk low
CN¥8,83
EPS
CN¥0,31
Shares outstanding
223,09 m
No. of employees
818
Open
CN¥10,48
High
CN¥10,69
Low
CN¥10,20
Mkt. cap
2,40 mjd
Avg. vol.
5,31 m
Volume
5,09 m
Dividend
0,75%
Quarterly dividend
CN¥0,02
Ex-dividend date
26 Jun. 2026
P/E ratio
33,00
52-wk high
CN¥15,55
52-wk low
CN¥8,83
EPS
CN¥0,31
Shares outstanding
223,09 m
No. of employees
818
News stories
From web sources and news partners
About Shanghai No.1 Pharmacy Co Ltd
CEO-
Employees818
Founded23 Sep. 1992
Headquarters-
SectorDrug
Websiteshdyyy.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
542,48 m
591,16 m
484,56 m
497,01 m
Cost of goods sold
456,34 m
501,71 m
413,36 m
418,65 m
Cost of revenue
456,34 m
501,71 m
413,36 m
418,65 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85,76 m
89,74 m
72,40 m
81,79 m
Operating expense
86,94 m
93,69 m
72,76 m
84,41 m
Total operating expenses
543,28 m
595,40 m
486,12 m
503,06 m
Operating income
-795,06 k
-4,25 m
-1,56 m
-6,05 m
Other non operating income
-841,60 k
232,61 k
-117,44 k
-82,80 k
EBT including unusual items
52,37 m
5,93 m
30,96 m
3,05 m
EBT excluding unusual items
1,25 m
-1,22 m
1,45 m
761,28 k
Income tax expense
12,68 m
1,41 m
7,30 m
214,41 k
Effective tax rate
24,20%
23,82%
23,57%
7,04%
Other operating expenses
1,28 m
2,02 m
994,91 k
1,28 m
Net income
39,25 m
4,48 m
23,26 m
2,91 m
Net profit margin
7,23%
0,76%
4,80%
0,58%
Earnings per share
-
-
-
-
Interest and investment income
4,07 m
5,41 m
3,95 m
7,63 m
Interest expense
-1,11 m
-1,02 m
-815,89 k
-668,37 k
Net interest expenses
2,96 m
4,39 m
3,13 m
6,96 m
Depreciation and amortization charges
-
-
-
-
EBITDA
819,56 k
-2,43 m
252,64 k
-4,23 m
Gain or loss from assets sale
404,94 k
-50,18 m
-
-30,73 m
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme